,Date,Study,Study Link,Journal,Study Type,Material,Method,Days After Onset/Admission (+) Covid-19 Presence (maximum unless otherwise stated),Property 2,Conclusion,Measure of Evidence,Added on
0,2020-04-03,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",https://www.sciencedirect.com/science/article/pii/S0140673620305663?casa_token=At8bltLokFMAAAAA:EZEVZRa9aH-LFUs4mrJsE45Ww8EnPcCGZrdB5MSV0IcEPfmVchwvUSgkDGHIkIj6qO6JvYxH8Lw,The Lancet,Retrospective cohort,Nasopharyngeal,RT-PCR confirmed,median: 20; range: 8-37,-,Median shedding with lopinavir/ritonavir = 22 days; median in severe cases = 22 days; median in critical cases = 24 days,patients: 29,04/13/2020
1,2020-03-30,Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients,https://www.medrxiv.org/content/10.1101/2020.03.28.20043059v1,medRxiv,Prospective Cohort,Nasopharyngeal,RT-PCR confirmed,median: 10,-,Viral titers of nasal-throat swabs peaked at 6-9 DAO,patients: 23,04/09/2020
2,2020-03-26,Viral Kinetics and Antibody Responses in Patients with COVID-19,https://doi.org/10.1101/2020.03.24.20042382,medRxiv,Prospective Cohort,Nasopharyngeal,qRT-PCR confirmed,median: 12; range: 3-38,-,Nasophayngeal is a major shedding area.,patients: 67,04/13/2020
3,2020-03-19,Viral dynamics in mild and severe cases of COVID-19,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30232-2/fulltext,The Lancet Infectious Disease,Prospective Cohort,Nasopharyngeal,RT-PCR confirmed,mean: 15,-,"Mild illness cleared by ~10 DAO, severe cases last longer.",patients: 76; severity: mild,04/13/2020
4,2020-03-19,Viral dynamics in mild and severe cases of COVID-19,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30232-2/fulltext,The Lancet Infectious Disease,Prospective Cohort,Nasopharyngeal,RT-PCR confirmed,mean: 25,-,"Mild illness cleared by ~10 DAO, severe cases last longer.",patients: 76; severity: severe,04/13/2020
5,2020-03-15,Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098032/,International Journal of Biological Sciences,Prospective Cohort,Nasopharyngeal,RT-PCR confirmed,mean: 24,-,Average RNA conversion time for NPS is 18.2 days (SD: 4.6),patients: 10,04/13/2020
6,2020-03-12,Patients with respiratory symptoms are at greater risk of COVID-19 transmission,https://www.resmedjournal.com/article/S0954-6111(20)30075-5/pdf,Respiratory medicine,Prospective Cohort,Nasopharyngeal,RT-PCR confirmed,median: 17 days,,respiratory symptoms increase the duration of COVID-19 testing by nasopharyngeal swabs,patients: 26,05/11/2020
7,2020-03-12,Patients with respiratory symptoms are at greater risk of COVID-19 transmission,https://www.resmedjournal.com/article/S0954-6111(20)30075-5/pdf,Respiratory medicine,Prospective Cohort,Nasopharyngeal,RT-PCR confirmed,median: 13 days,,respiratory symptoms increase the duration of COVID-19 testing by nasopharyngeal swabs,patients: 56,05/11/2020
8,2020-03-03,Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore,https://doi.org/10.1001/jama.2020.3204,JAMA,Descriptive case series,Nasopharyngeal,RT-PCR confirmed,median: 12; range: 1-24,-,83% of patients had nasopharynx viral shedding >7 days,patients: 18,04/08/2020
